Vomiting in an infant with congenital nephrotic syndrome: Questions

Toshiyuki Takahashi1, Yasuyuki Sato2, Takeshi Yamazaki2

  • 1Department of Pediatrics, Hokkaido University Hospital, Kita 15-jo Nishi 7-Chome, Kita Ward, Sapporo City, Hokkaido, Japan. t-toshi@med.hokudai.ac.jp.

Insights

Congenital nephrotic syndrome (CNS) infants may have a higher risk of hypertrophic pyloric stenosis (HPS). Early intervention for gastric outlet obstruction can improve poor weight gain in these patients.

Area of Science:

  • Pediatric Nephrology
  • Gastroenterology

Background:

  • Congenital nephrotic syndrome (CNS) frequently causes failure to thrive.
  • A prior study noted 12% of infants with CNS had hypertrophic pyloric stenosis (HPS).
  • The association between CNS and HPS remains unclear.

Observation:

  • A 4-month-old girl with CNS presented with poor weight gain.
  • Ultrasound revealed thickened pyloric mucosal/submucosal layers and muscle hypertrophy, preceding typical HPS symptoms.
  • Pyloroplasty was performed to address the gastric outlet obstruction.

Findings:

  • The patient experienced improved weight gain after pyloroplasty.
  • Gastric outlet obstruction may be linked to poor growth in CNS patients.
  • Thickened pyloric antrum tissues could contribute to HPS prevalence in CNS.

Implications:

  • Suspect HPS in CNS infants with poor weight gain, even without classic symptoms.
  • Prompt surgical intervention like pyloroplasty can enhance growth outcomes.
  • Understanding this association may improve management of CNS complications.
Abstract

Related Concept Videos

Pathophysiology of Vomiting01:22

Pathophysiology of Vomiting

Vomiting is a complex physiological response to expel harmful or irritating substances from the body. It's a defensive mechanism triggered by stimuli like poisons, microbial toxins, cytotoxic drugs, and mechanical abdominal distension. The process is centrally coordinated by the vomiting (or emetic) center located in the medulla of the brainstem. This area, rich in muscarinic M1, histamine H1, neurokinin 1 (NK1), and serotonin 5-HT3 receptors, coordinates the act of vomiting through...
3.7K
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
821
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
412
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
294
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
1.2K
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
876